Monoclonal Antibodies against Human Factor VIII Molecular Neutralize Antihemophilic Factor and Ristocetin Cofactor Activities. - Normandie Université Access content directly
Journal Articles Proceedings of the National Academy of Sciences of the United States of America Year : 1982

Monoclonal Antibodies against Human Factor VIII Molecular Neutralize Antihemophilic Factor and Ristocetin Cofactor Activities.

Abstract

A series of monoclonal antibodies have been raised against a preparation of the factor VIII/von Willebrand factor molecule. Of the seven hybridomas showing specific activity against the factor VIII molecule in a solid-phase radioimmunoassay, three (F4.55, F4.77, and F4.264) have been shown to partially inhibit ristocetin-induced platelet aggregation and two (F4.115 and F4.415) inhibit the antihemophilic activity of the factor VIII molecule. An additional monoclonal antibody was directed against a contaminant of the factor VIII preparation and is an antifibrinogen antibody.

Dates and versions

hal-01762075 , version 1 (09-04-2018)

Identifiers

Cite

Brigitte Sola, Avner P, Sultan Y, Jeanneau C, Maisonneuve P. Monoclonal Antibodies against Human Factor VIII Molecular Neutralize Antihemophilic Factor and Ristocetin Cofactor Activities.. Proceedings of the National Academy of Sciences of the United States of America, 1982, ⟨10.1073/pnas.79.1.183⟩. ⟨hal-01762075⟩

Collections

COMUE-NORMANDIE
23 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More